NKF K/DOQI GUIDELINES
Executive Summaries of 2000 Updates
Vascular Access |
Nutrition |
Chronic Kidney Disease |
History of DOQI
|
|
NKF K/DOQI GUIDELINES
Executive Summaries of 2000 Updates |
K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
BIBLIOGRAPHY
1. Jones CA, McQuillan GM, Kusek JW, Eberhardt MS, Herman WH, Coresh J, Salive M, Jones CP, Agodoa LY: Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 32:992-999, 1998 (erratum 35:178, 2000)
2. US Renal Data System. USRDS 1998 Annual Data Report, National
Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
Bethesda, MD, 1998
3. Sarnak MJ, Levey AS: Cardiovascular disease and
chronic renal disease: A new paradigm. Am
J Kidney Dis 35:S117-S131, 2000 (suppl 1)
4. US Renal Data System. USRDS 2000 Annual Data Report, National
Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
Bethesda, MD, 2000
5. Coresh J, Wei GL, McQuillan G, Brancati FL,
Levey AS, Jones C, Klag MJ: Prevalence of high blood pressure and elevated serum
creatinine level in the United States: Findings from the third National Health and
Nutrition Examination Survey (1988-1994). Arch Intern Med
161:1207-1216, 2001
6. Keane WF, Eknoyan G: Proteinuria, albuminuria,
risk, assessment, detection, elimination (PARADE): A position paper of the National Kidney
Foundation. Am
J Kidney Dis 33:1004-1010, 1999
7. Hogg RJ, Portmann RJ, Milliner D, Lemley KV,
Eddy A, Ingelfinger J: Evaluation and management of proteinuria and nephrotic syndrome in
children: Recommendations from a pediatric nephrology panel established at the National
Kidney Foundation conference on Proteinuria, Risk, Assessment, Detection, Elimination
(PARADE). Pediatrics
105:1242-1249, 2000
8. American Diabetes Association: Clinical
Practice Recommendations 2001. Diabetes
Care 24:S69-S72, 2001 (suppl 1)
9. Levey AS, Beto JA, Coronado BE, Eknoyan G,
Foley RN, Kasiske RL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA,
Wenger NK, Wilson PW, Wright JT Jr: Controlling the epidemic of cardiovascular disease in
chronic renal disease: What do we know? What do we need to learn? Where do we go from
here? Am
J Kidney Disease 32:853-905, 1998
10. McClellan WM, Knight DF, Karp H, Brown WW:
Early detection and treatment of renal disease in hospitalized diabetic and hypertensive
patients: Important differences between practice and published guidelines. Am
J Kidney Dis 29:368-375, 1997
11. Obrador GT, Ruthazer R, Arora P, Kausz AT,
Pereira BJ: Prevalence of and factors associated with suboptimal care before initiation of
dialysis in the United States. J
Am Soc Nephrol 10:1793-1800, 1999
12. Kannel WB, Stampfer MJ, Castelli WP, Verter
J: The prognostic significance of proteinuria: The Framingham study. Am
Heart J 108:1347-1352, 1984
13. Iseki K, Iseki C, Ikemiya Y, Fukiyama K: Risk
of developing end-stage renal disease in a cohort of mass screening. Kidney
Int 49:800-805, 1996
14. Perneger TV, Brancati FL, Whelton PK, Klag
MJ: Studying the causes of kidney disease in humans: A review of methodologic obstacles
and possible solutions. Am
J Kidney Dis 25:722-731, 1995
15. Pereira KI: Optimization of pre-ESRD care:
The key to improved dialysis outcomes. Kidney
Int 57:351-365, 2000
16. NKF-K/DOQI Clinical Practice Guidelines for
Peritoneal Dialysis Adequacy: Update 2000. Am
J Kidney Dis 37:S65-S136, 2001 (suppl 1)
17. Levey AS, Bosch JP, Lewis JB, Greene T,
Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum
creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med
130:461-470, 1999
18. Levey AS, Greene T, Kusek JW, Beck GJ: A
simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc
Nephrol 11:A0828, 2000 (abstr)
19. Warram JH, Gearin G, Laffel L, Krolewski AS:
Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy
defined by urinary albumin/creatinine ratio. J
Am Soc Nephrol 7:930-937, 1996
20. Barratt TM, McLaine PN, Soothill JF: Albumin
excretion as a measure of glomerular dysfunction in children. Arch
Dis Child 45:496-501, 1970
21. Davies AG, Postlethwaite RJ, Price DA, Burn
JL, Houlton CA, Fielding BA: Urinary albumin excretion on school children. Arch
Dis Child 59:625-630, 1984
22. Bangstad HJ, Dahl-Jorgensen K, Kjaersgaard P,
Mevold K, Hanssen KF: Urinary albumin excretion rate and puberty in non-diabetic children
and adolescents. Acta
Paediatr 82:857-862, 1993
23. Cowell CT, Rogers S, Silink M: First morning
urinary albumin concentration is a good predictor of 24-hour urinary albumin excretion in
children with type 1 (insulin-dependent) diabetes. Diabetologia
29:97-99, 1986
24. Salardi S, Cacciari, Pascucci MG, Giambiasi
E, Tacconi M, Tazzari R: Microalbuminuria in diabetic children and adolescents.
Relationship with puberty and growth hormone. Acta
Paediatr Scand 79:437-433, 1990
25. Marshall SM, Hackett A, Court S, Parkin M,
Alberti KG: Albumin excretion in children and adolescents with insulin-dependent diabetes.
Diabetes
Res 3:345-348, 1986
26. Ellis D, Buffone GJ: New approach to
evaluation of proteinuric states. Clin
Chem 23:666-670, 1977
27. Mathiesen ERS, Saurbrey N, Hommel E, Parving
HH: Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes
mellitus. Diabetologia
29:640-633, 1986
28. Brøchner-Mortensen J, Ditzel J, Mogensen CE,
Rodbro P: Microvascular permeability to albumin and glomerular filtration rate in diabetic
and normal children.
Diabetologia 16:307-311, 1979
29. Mortensen HB, Marinelli K, Norgaard K, Main
K, Kastrup KW, Ibsen KK, Villumsen J, Parving HH: A nation-wide cross-sectional study of
urinary albumin excretion rate, arterial blood pressure and blood glucose control in
Danish children with type 1 diabetes mellitus. Danish Study Group of Diabetes in
Childhood. Diabet
Med 10:887-977, 1990
30. Dahlquist G, Rudberg S: The prevalence of
microalbuminuria in diabetic children and adolescents and its relation to puberty. Acta
Paediatr Scand 76:795-8000, 1987
31. Erman A, van Dyk DJ, Rabinov M, Boner G,
Rosenfeld JB: Urinary albumin excretion in the healthy population. Isr
J Med Sci 26:389-392, 1990
32. Holl RW, Grabert M, Thon A, Heinze E: Urinary
excretion of albumin in adolescents with type 1 diabetes: Persistent versus intermittent
microalbuminuria and relationship to duration of diabetes, sex, and metabolic control. Diabetes Care 22:1555-1560,
1999
33. Huttunen NP, Kaar M, Puukka R, Akerblom HK:
Exercise-induced proteinuria in children and adolescents with type 1 (insulin dependent)
diabetes. Diabetologia
21:495-497, 1981
34. Chiumello G, Bognetti E, Meschi F, Carra M,
Balzano E: Early diagnosis of subclinical complications in insulin dependent diabetic
children and adolescents.
J Endocrinol Invest 12:101-104, 1989 (suppl 3)
35. Laborde K, Levy-Marchal C, Kindermans C,
Dechaux M, Czernichow P, Sachs C: Glomerular function and microalbuminuria in children
with insulin-dependent diabetes. Pediatr
Nephrol 4:39-433, 1990
36. Mullis P, Kochli HP, Zuppinger K, Schwarz HP:
Intermittent microalbuminuria in children with type 1 diabetes mellitus without clinical
evidence of nephropathy. Eur
J Pediatr 147:385-388, 1988
37. Elises JS, Griffiths PD, Hocking MD, Taylor
CM, White RH: Simplified quantification of urinary protein excretion in children. Clin
Nephrol 30:225-229, 1988
38. Ginevri F, Piccotti E, Alinovi R, DeToni T,
Biagini C, Chiggeri GM, Gusmano R: Reversible tubular proteinuria precedes
microalbuminuria and correlates with the metabolic status of diabetic children. Pediatr
Nephrol 7:23-26, 1993
39. Houser MT: Characterization of proteinuria
using random urine samples. Int
J Pediatr Nephrol 7:197-202, 1986
40. Hjorth L, Helin I, Grubb A: Age-related
reference limits for urine levels of albumin, orosomucoid, immunoglobulin G and protein HC
in children. Scand
J Clin Lab Invest 60:65-73, 2000
41. Schultz CJ, Konopelska-Bahu T, Dalton RN,
Carroll TA, Stratton I, Gale EA, Neil A, Dunger DB: Microalbuminuria prevalence varies
with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a
longitudinal study. Oxford Regional Prospective Study Group. Diabetes Care 22:495-502,
1999
42. Gibb D, Shah V, Preece M, Barratt TM:
Variability of urine albumin excretion in normal and diabetic children. Pediatr
Nephrol 3:414-419, 1989
43. Schultz CJ, Dalton RN, Turner C, Neil HA,
Dunger DB: Freezing method affects the concentration and variability of urine proteins and
the interpretation of data on microalbuminuria. The Oxford Regional Prospective Study
Group. Diabet
Med 17:7-14, 2000
44. Yap C, Yap HK, Chio LF: Urine
microalbumin/creatinine ratios in Singapore children. J
Singapore Paediatr Soc 33:101-106, 1991
45. Jefferson IG, Greene SA, Smith MA, Smith RF,
Griffin NKG, Baum JD: Urine albumin to creatinine ratio-response to exercise in diabetes. Arch
Dis Child 60:305-310, 1985
46. Cesarini PR, Ferreira SR, Vivolo MA, Zanella
MT: Different urinary albumin responses to submaximal exercise by normoalbuminuric
diabetic children and controls. Brazilian
J Med Biol Res 29:1603-1610, 1996
47. Murakami M, Yamamoto H, Ueda Y, Murakami K,
Yamauchi K: Urinary screening of elementary and junior high-school children over a 13-year
period in Tokyo. Pediatr
Nephrol 5:50-53, 1991
48. Lin CY, Sheng CC, Chen CH, Lin CC, Chou P:
The prevalence of heavy proteinuria and progression risk factors in children undergoing
urinary screening. Pediatr
Nephrol 14:953-959, 2000
49. Vehaskari VM, Rapola J: Isolated proteinuria:
Analysis of a school-age population. J
Pediatr 101:661-688, 1982
50. Wagner MG, Smith FG Jr, Tinglof BO Jr,
Cornberg E: Epidemiology of proteinuria. A study of 4,807 schoolchildren.
J Pediatr 73:825-832, 1968
51. Randolph MF, Greenfield M: Proteinuria. A
six-year study of normal infants, preschool, and school-age populations previously
screened for urinary tract disease. Am
J Dis Child 114:631-638, 1967
52. Johnson A, Heap GJ, Hurley BP: A survey of
bacteriuria, proteinuria and glycosuria in five-year-old schoolchildren in canberra. Med
J Aust 2:122-124, 1974
53. Wolman IJ: The incidence, causes and
intermittency of proteinuria in young men. Am J Med Sci 210:86-100, 1945
54. Kunin CM, Deutscher R, Paquin A Jr: Urinary
tract infection in school children: An epidemiologic, clinical and laboratory study.
Medicine (Baltimore) 43:91-130, 1964
55. Meadow SR, White RH, Johnston NM: Prevalence
of symptomless urinary tract disease in Birmingham schoolchildren. I. Pyuria and
bacteriuria. BMJ
3:81-84, 1969
56. Mitchell N, Stapleton FB: Routine admission
urinalysis examination in pediatric patients: A poor value. Pediatrics
86:345-349, 1990
57. Hamill SM, Blackfan KD: Frequency and
significance of albumin in the urines of normal children. Am J Dis Child 1:139-163, 1911
58. Dodge WF, West EF, Smith EH, Bruce H III:
Proteinuria and hematuria in schoolchildren: Epidemiology and early natural history. J
Pediatr 88:327-347, 1976
59. Hogg RJ, Harris S, Lawrence DM, Henning PH,
Wigg N, Jureidini KF: Renal tract abnormalities detected in Australian preschool children.
J
Paediatr Child Health 34:420-424, 1998
60. Silverberg DS: City-wide screening for
urinary abnormalities in schoolboys. Can
Med Assoc J 7:410-422, 1974
61. Silverberg DS, Allard MJ, Ulan RA, Beamish
WE, Lentle BC, McPhee MS, Grace MG: City-wide screening for urinary abnormalities in
schoolgirls. Can
Med Assoc J 109:981-985, 1973
62. Bashford HH: Adolescent albuminuria:
Incidence, significance, and after-history. Lancet 2:1305-1307, 1926
63. Mueller PW, Caudill SP: Urinary albumin
excretion in children: Factors related to elevated excretion in the United States
population.
Ren Fail 21:293-302, 1999
64. Pugia MJ, Lott JA, Kajima J, Saambe T, Sasaki
M, Kuromoto K, Nakamura R, Fusegawa H, Ohta Y: Screening school children for albuminuria,
proteinuria and occult blood with dipsticks. Clin
Chem Lab Med 37:149-157, 1999
65. Hoy WE, Mathews JD, McCredie DA, Pugsley DJ,
Hayhurst BG, Rees M, Kile E, Walker KA, Wang Z: The multidimensional nature of renal
disease: Rates and associations of albuminuria in an Australian Aboriginal community. Kidney
Int 54:1296-1304, 1998
66. Bernard A, Stolte H, De Broe ME, Mueller PW,
Mason H, Lash LH, Fowler BA: Urinary biomarkers to detect significant effects of
environmental and occupational exposure to nephrotoxins. IV. Current information on
interpreting the health implications of tests. Ren
Fail 19:553-566, 1997
67. Smith HW: Comparative physiology of the
kidney, in Smith HW (ed): The Kidney: Structure and Function in Health and Disease. New
York, NY, Oxford University Press, 1951, pp 520-574
68. Atiyeh BA, Dabbagh SS, Gruskin AB: Evaluation
of renal function during childhood. Pediatr
Rev 17:175-179, 1996
69. Heilbron DC, Holliday MA, Al-Dahwi A, Kogan
BA: Expressing glomerular filtration rate in children. Pediatr
Nephrol 5:5-11, 1991
70. Coulthard MG: Maturation of glomerular
filtratior in preterm and mature babies.
Early Hum Dev 11:281-292, 1985
71. Schwartz GJ, Feld LG, Langford DJ: A simple
estimate of glomerular filtration rate in full-term infants during the first year of life.
J
Pediatr 104:849-854, 1984
72. Davies DF, Shock NW: Age changes in
glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in
adult males. J Clin Invest 29:496-507, 1950
73. Wesson LG: Physiology of the Human Kidney.
New York, Grune and Stratton, 1969
74. Watkins DM, Shock NW: Age-wise standard value
for Cin, CPAH, and TmPAH in adult males. J Clin Invest
34:969, 1955
75. NKF-K/DOQI Clinical Practice Guidelines for
Nutrition in Chronic Renal Failure. Am
J Kidney Dis 35:S1-S140, 2000 (suppl 2)
76. Levey AS, Greene T, Burkart J: Comprehensive
assessment of the level of renal function at the initiation of dialysis in the MDRD study.
J Am Soc Nephrology 9:153A, 1998 (abstr)
77. Obrador GT, Arora P, Kausz AT, Ruthazer R,
Pereira BJ, Levey AS: Level of renal function at the initiation of dialysis in the U.S.
end-stage renal disease population. Kidney
Int 56:2227-2235, 1999
78. Arora P, Obrador GT, Ruthazer R, Kausz
AT, Meyer KB, Jenuleson CS, Pereira BJ: Prevalence, predictors, and consequences of late
nephrology referral at a tertiary care center. J Am Soc Nephrol 10:1281-1286, 1999
79. Jungers P, Zingraff J, Albouze G, Chauveau P,
Page B, Hannedouche T, Man NK: Late referral to maintenance dialysis: Detrimental
consequences. Nephrol
Dial Transplant 8:1089-1093, 1993
80. Sesso R, Yoshihiro MM: Time of diagnosis of
chronic renal failure and assessment of quality of life in haemodialysis patients. Nephrol
Dial Transplant 12:2111-2116, 1997
81. Fink JC, Burdick RA, Kurth SJ, Blahut SA,
Armistead NC, Turner MS, Shickle LM, Light PD: Significance of serum creatinine values in
new end-stage renal disease patients. Am
J Kidney Dis 34:694-701, 1999
82. Iofel Y, Dawood M, Valcourt JS, Ifudu O:
Initiation of dialysis is not delayed in whites with progressive renal failure. ASAIO
J 44:M598-M600, 1998
83. Ifudu O, Dawood M, Homel P, Friedman EA:
Excess morbidity in patients starting uremia therapy without prior care by a nephrologist.
Am
J Kidney Dis 28:841-845, 1996
84. Guidance for Industry Pharmacokinetics in
Patients with Impaired Renal Function: Study Design, Data Analysis and Impact on
Dosing and Labeling. Washington, DC, US Department of Health and Human Services, Food and
Drug Administration, Center for Drug Evaluation and Research, Center for Biologics
Evaluation and Research, 1998
85. German PS: Compliance with chronic disease. Hypertension
11:1156-1160, 1988
86. Frazier PA, Davis-Ali SH, Dahl KE: Correlates
of noncompliance among renal transplant recipients. Clin
Transplant 8:550-557, 1994
87. Kiley DJ, Lam CS, Pollack R: A study of
treatment compliance following kidney transplantation. Transplantation
55:51-56, 1993
88. DiMatteo MR, Lepper HS, Croghan TW:
Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the
effects of anxiety and depression on patient adherence. Arch Intern Med
:2101-2107, 2000
89. Schneider MS, Friend R, Whitaker P, Wadhwa
NK: Fluid noncompliance and symptomatology in end-stage renal disease: Cognitive and
emotional variables. Health
Psychol 10:209-215, 1991
90. Shaw E, Anderson JG, Maloney M, Jay SJ, Fagan
D: Factors associated with noncompliance of patients taking antihypertensive medications. Hospital
Pharm 30:201-203, 1995
91. McLane CG, Zyzanski SJ, Flocke SA: Factors
associated with medication noncompliance in rural elderly hypertensive patients. Am
J Hypertens 8:206-209, 1995
92. Christensen AJ, Smith TW, Turner CW, Holman
JM, Gregory MC, Rich MA: Family support, physical impairment, and adherence in
hemodialysis: An investigation of main and buffering effects. J
Behav Med 15:313-325, 1992
93. Billups SJ, Malone DC, Carter BL: The
relationship between drug therapy noncompliance and patient characteristics,
health-related quality of life, and health care costs. Pharmacotherapy
20:941-949, 2000
94. McGrath JM: Physicians’ perspectives on
communicating prescription drug information. Qual
Health Res 9:731-745, 1999
95. Dusing R, Weisser B, Mengden T, Vetter H:
Changes in antihypertensive therapy: The role of adverse effects and compliance. Blood
Press 7:313-315, 1998
96. Johnson MJ, Williams M, Marshall ES: Adherent
and nonadherent medication-taking in elderly antihypertensive patients. Clin
Nurs Res 8:318-335, 1999
97. Sharkness CM, Snow DA: The patient’s
view of hypertension and compliance. Am
J Prev Med 8:141-146, 1992
98. Monane M, Bohn RL, Gurwitz JH, Glynn RJ,
Levin R, Avorn J: Compliance with antihypertensive therapy among elderly Medicaid
enrollees: The roles of age, gender, and race. Am
J Public Health 86:1805-1808, 1996
99. Wright SJ: “Non-compliance”:
Meaningful construct or destructive, sticky, stigmatizing label? Edtna
Erca J 24:35-38, 1998
100. 27th Bethesda Conference. Matching the
Intensity of Risk Factor Management with the Hazard for Coronary Disease Events. September
14-15, 1995. J
Am Coll Cardiol 27:957-1047, 1996
101. Harris MI, Flegal KM, Cowie CC, Eberhardt
MS, Goldstein DE, Little RR, Wiedmeyet H-M, Byrd-Holt DD: Prevalence of diabetes, impaired
fasting glucose, and impaired glucose tolerance in U.S. adults: The Third National Health
and Nutrition Examination Survey, 1988-1994. Diabetes Care 21:518-524,
1998
102. Burt VL, Whelton P, Roccella EJ, Brown C,
Cutler JA, Higgins M, Horan MJ, Labarthe D: Prevalence of hypertension in the US adult
population. Hypertension
25:305-313, 1995
103. Lawrence RC, Helmick CG, Arnett FC, Deyo
RA, Felson DT, Giannini EH, Heyse ST, Hirsch R, Hochberg MC, Hunder GG, Liang MH, Pillemer
SR, Steen VD, Wolfe F: Estimates of the prevalence of arthritis and selected
musculoskeletal disorders in the United States. Arthritis
Rheum 41:778-799, 1998
104. US
Renal Data System. Excerpts from the 2000 US Renal Data System Annual Data Report:
Atlas of End Stage Renal Disease in the United States. Am J Kidney Dis 36:S1-S279, 2000
(suppl 2)
105. Profiles of General Demographic
Characteristics: 2000 Census of Population and Housing, United States. Washington, DC, US
Government Printing Office, 2001
106. Day JC: Population Projections of the
United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050. Washington, DC, US
Government Printing Office, 1996
107. Elixhauser A, Klemstine K, Steiner C,
Bierman A: Procedures in U.S. Hospitals, 1997. Vol. HCUP Fact Book No. 2. Rockville, MD,
Agency for Healthcare Resarch and Quality, 2001
108. HCUPnet: Healthcare Cost and Utilization
Project. Website: www.ahrq.gov/data/hcup/hcupnet.htm,
7/4
109. McGoldrick MD, Bailie GR: Nonnarcotic analgesics: Prevalence and estimated
economic impact of toxicities. Ann
Pharmacother 31:221-227, 1997
110. Fries JF: NSAID gastropathy: The second
most deadly rheumatic disease? Epidemiology and risk appraisal. J
Rheumatol 18:6-10, 1991
111. Rose BD: Chapter 3: Renal Circulation and
Glomerular Filtration Rate: Clinical Physiology of Acid-Base and Electrolyte Disorders.
New York, NY, McGraw Hill, 1984
112. Lindeman RD, Tobin J, Shock NW:
Longitudinal studies on the rate of decline in renal function with age. J Am
Geriatr Soc 33:278-285, 1985
113. Perrone RD, Madias NE, Levey AS: Serum
creatinine as an index of renal function: New insights into old concepts. Clin
Chem 38:1933-1953, 1992
114. Perrone RD, Steinman TI, Beck GJ, Skibinski
CI, Royal HD, Lawlor M, Hunsicker LG: Utility of radioscopic filtration markers in chronic
renal insufficiency: Simultaneous comparison of 125I-iothalamate, 169Yb-DPTA, and inulin.
The Modification of Diet in Renal Diseases Study. Am
J Kidney Dis 16:224-235, 1990
115. Wilson DM, Bergert JH, Larson TS, Liedtke
RR: GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. Am
J Kidney Dis 30:646-652, 1997
116. Deinum J, Derkx FH: Cystatin for estimation
of glomerular filtration rate? Lancet
356:1624-1625, 2000
117. Shemesh O, Golbetz H, Kriss JP, Myers BD:
Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney
Int 28:830-838, 1985
118. Levey AS, Perrone RD, Madias NE: Serum
creatinine and renal function. Annu
Rev Med 39:465-490, 1988
119. Levey AS: Assessing the effectiveness of
therapy to prevent progression of renal disease. Am
J Kidney Dis 22:207-214, 1993
120. Gault MH, Longerich LL, Harnett JD,
Wesolowski C: Predicting glomerular function from adjusted serum creatinine. Nephron
62:249-256, 1992
121. Cockcroft DW, Gault MH: Prediction of
creatinine clearance from serum creatinine. Nephron
16:31-41, 1976
122. Jelliffe RW: Estimation of creatinine
clearance when urine cannot be collected. Lancet
1:975-976, 1971
123. Schwartz GJ, Gauthier B: A simple estimate
of glomerular filtration rate in adolescent boys. J
Pediatr 106:522-526, 1985
124. Schwartz GJ, Haycock GB, Edelmann CM Jr,
Spitzer A: A simple estimate of glomerular filtration rate in children derived from body
length and plasma creatinine. Pediatrics
58:259-263, 1976
125. Brion LP, Boeck MA, Gauthier B, Nussbaum
MP, Schwartz GJ: Estimation of glomerular filtration rate in anorectic adolescents. Pediatr
Nephrol 3:16-21, 1989
126. Brion LP, Fleischman AR, McCarton C,
Schwartz GJ: A simple estimate of glomerular filtration rate in low birth weight infants
during the first year of life: Noninvasive assessment of body composition and growth. J
Pediatr 109:698-707, 1986
127. Counahan R, Chantler C, Ghazali S, Kirkwood
B, Rose F, Barratt TM: Estimation of glomerular filtration rate from plasma creatinine
concentration in children. Arch
Dis Child 51:875-878, 1976
128. Barratt TM, Chantler C, Lederman S, Rigden
SP: Assessment of renal function. Am
J Kidney Dis 7:347-349, 1986
129. Morris MC, Allanby CW, Toseland P, Haycock
GB, Chantler C: Evaluation of a height/plasma creatinine formula in the measurement of
glomerular filtration rate. Arch
Dis Child 57:611-615, 1982
130. Jelliffe RW: Letter: Creatinine clearance:
Bedside estimate. Ann
Intern Med 79:604-605, 1973
131. Mawer GE, Lucas SB, Knowles BR, Stirland
RM: Computer-assisted prescribing of kanamycin for patients with renal insufficiency. Lancet
1:12-15, 1972
132. Hull JH, Hak LJ, Koch GG, Wargin WA, Chi
SL, Mattocks AM: Influence of range of renal function and liver disease on predictability
of creatinine clearance. Clin
Pharmacol Therapeutics 29:516-521, 1981
133. Gates GF: Creatinine clearance estimation
from serum creatinine values: An analysis of three mathematical models of glomerular
function. Am
J Kidney Dis 5:199-205, 1985
134. Bjornsson TD, Cocchetto DM, McGowan FX,
Verghese CP, Sedor F: Nomogram for estimating creatinine clearance. Clin
Pharmacokinet 8:365-369, 1983
135. Toto RD, Kirk KA, Coresh J, Jones C, Appel
L, Wright J, Campese V, Olutade B, Agodoa L: Evaluation of serum creatinine for estimating
glomerular filtration rate in African Americans with hypertensive nephrosclerosis: Results
from the African-American Study of Kidney Disease and Hypertension (AASK) Pilot Study. J
Am Soc Nephrol 8:279-287, 1997
136. Agarwal R, Nicar M: A comparative analysis
of formulas used to predict creatinine clearance. J Am Soc Nephrol 5:386, 1994
137. Davis GA, Chandler MH: Comparison of
creatinine clearance estimation methods in patients with trauma. Am
J Health Syst Pharm 53:1028-1032, 1996
138. Edwards KDG, Whyte HM: Plasma creatinine
level and creatinine clearance as a test of renal function. Aust Ann Med 8:218-224, 1959
139. Hallynck T, Soep HH, Thomis J, Boelaert J,
Daneels R, Fillastre JP, De Rosa F, Rubinstein E, Hatala M, Spousta J, Dettli L:
Prediction of creatinine clearance from serum creatinine concentration based on lean body
mass. Clin
Pharmacol Therapeutics 30:414-421, 1981
140. Mogensen CE, Heilskov NS: Prediction of GFR
from serum creatinine. Acta
Endocrinol (Copenh) Suppl 238:109, 1980
141. Nankivell BJ, Allen RDM, O’Connell PJ,
Chapman JR: Erythrocytes after renal transplantation: Risk factors and relationship with
GFR. Clin
Transplant 9:375-382, 1995
142. Robinson BA, Frampton CM, Colls BM,
Atkinson CH, Fitzharris BM: Comparison of methods of assessment of renal function in
patients with cancer treated with cisplatin, carboplatin or methotrexate. Aust
NZ J Med 20:657-662, 1990
143. Rowe JWA, Andres R, Tobin JD, Norris AH,
Shock NW: The effect of age on creatinine clearance in men: A cross-sectional and
longitudinal study. J
Gerontol 31:155-163, 1976
144. Salazar DE, Corcoran GB: Predicting
creatinine clearance and renal drug clearance in obese patients from estimated fat-free
body mass. Am
J Med 84:1053-1060, 1988
145. Sanaka M, Takano K, Shimakura K, Koike Y,
Mineshita S: Serum albumin for estimating creatinine clearance in the elderly with muscle
atrophy. Nephron
73:137-144, 1996
146. Siersbaek-Nielsen K, Hansen JM, Kampmann J,
Kristensen M: Rapid evaluation of creatinine clearance. Lancet
1:1133-1134, 1971
147. Tougaard L, Brochner-Mortensen J: An
individual nomogram for determination of glomerular filtration rate from plasma
creatinine. Scand
J Clin Lab Invest 36:395-397, 1976
148. Yukawa E, Hamachi Y, Higuchi S, Aoyama T:
Predictive performance of equations to estimate creatinine clearance from serum creatinine
in Japanese patients with congestive heart failure. Am
J Ther 6:71-76, 1999
149. Shull BC, Haughley D, Koup JR, Baliah T, Li
PK: A useful method for predicting creatinine clearance in children. Clin
Chem 24:1167-1199, 1978
150. Traub SL, Johnson CE: Comparison of methods
of estimating creatinine clearance in children. Am
J Hosp Pharm 37:195-201, 1980
151. Ghazali S, Barratt TM: Urinary excretion of
calcium and magnesium in children. Arch
Dis Child 49:97-101, 1974
152. Evans GO, Griffiths PD: Limitations
concerning the use in children of the relationship between plasma creatinine and body
height to derive glomerular filtration rate. Ann
Clin Biochem 18:295-298, 1981
153. Hernandez de Acevedo LH, Johnson CE:
Estimation of creatinine clearance in children: Comparison of six methods. Clin
Pharm 1:158-161, 1982
154. Jelliffe RW, Jelliffe SM: A computer
program for estimation of creatinine clearance from unstable serum creatinine levels, age,
sex, and weight. Math Biosci 14:17-24, 1972
155. Paap CM, Nahata MC: Prospective evaluation
of ten methods for estimating creatinine clearance in children with varying degrees of
renal dysfunction. J
Clin Pharm Therapeutics 20:67-73, 1995
156. Parkin A, Smith HC, Brocklebank JT: Which
routine test for kidney function? Arch
Dis Child 64:1261-1263, 1989
157. Rudd GD, Hull JH, Morris CR, Bryan CK:
Estimating creatinine clearance in children: Comparison of three methods. Am
J Hosp Pharm 37:1514-1517, 1980
158. van den Anker JN, de Groot R, Broerse HM,
Sauer PJ, van der Heijden BJ, Hop WC, Lindemans J: Assessment of glomerular filtration
rate in preterm infants by serum creatinine: Comparison with inulin clearance. Pediatrics
96:1156-1158, 1995
159. Rolin HA III, Hall PM, Wei R: Inaccuracy of
estimated creatinine clearance for prediction of iothalamate glomerular filtration rate. Am
J Kidney Dis 4:48-54, 1984
160. Lemann J, Bidani AK, Bain RP, Lewis EJ,
Rohde RD: Use of the serum creatinine to estimate glomerular filtration rate in health and
early diabetic nephropathy. Collaborative Study Group of Angiotensin Converting Enzyme
Inhibition in Diabetic Nephropathy. Am
J Kidney Dis 16:236-243, 1990
161. Charleson HA, Bailey RR, Stewart A: Quick
prediction of creatinine clearance without the necessity of urine collection. N
Z Med J 92:425-426, 1980
162. Lewis J, Agodoa L, Cheek D, Greene T,
Middleton J, O’Connor D, Ojo A, Phillips R, Sika M, Wright J Jr: African-American
Study of Hypertension and Kidney Disease. Comparison of cross-sectional renal function
measurements in African Americans with hypertensive nephrosclerosis and of primary
formulas to estimate glomerular filtration rate. Am
J Kidney Dis 38:744-753, 2001
163. Waller DG, Fleming JS, Ramsey B, Gray J:
The accuracy of creatinine clearance with and without urine collection as a measure of
glomerular filtration rate. Postgrad
Med J 67:42-46, 1991
164. DeSanto NG, Coppola S, Anastasio P,
Coscarella G, Capasso G, Bellini L, Santangelo R, Massimo L, Siciliano A: Predicted
creatinine clearance to assess glomerular filtration rate in chronic renal disease in
humans. Am
J Nephrol 11:181-185, 1991
165. Bedros F, Kasiske B: Estimating GFR from
creatinine clearance in renal transplant recipients. J Am Soc Nephrol 9:666A, 1998 (abstr)
166. Goerdt PJ, Heim-Duthoy KL, Macres M, Swan
SK: Predictive performance of renal function estimate equations in renal allografts. Br
J Clin Pharmacol 44:261-265, 1997
167. Filler G, Priem F, Vollmer I, Gellermann J,
Jung K: Diagnostic sensitivity of serum cystatin for impaired glomerular filtration rate. Pediatr
Nephrol 13:501-505, 1999
168. Seikaly MG, Browne R, Bajaj G, Arant BS Jr:
Limitations to body length/serum creatinine ratio as an estimate of glomerular filtration
in children. Pediatr
Nephrol 10:709-711, 1996
169. Hellerstein S, Berenbom M, Alon US, Warady
BA: Creatinine clearance following cimetidine for estimation of glomerular filtration
rate. Pediatr
Nephrol 12:49-54, 1998
170. Guignard JP, Torrado A, Feldman H, Gautier
E: Assessment of glomerular filtration rate in children. Helv
Paediatr Acta 35:437-447, 1980
171. Stake G: Estimation of the glomerular
filtration rate in infants and children using iohexol and X-ray fluorescence technique, in
Department of Radiology, Section of Paediatric Radiology. Oslo, Norway, University of
Oslo, 1992
172. Seikaly MG, Browne R, Simonds N, Atkins C,
Alexander SR: Glomerular filtration rate in children following renal transplantation. Pediatr
Transplant 2:231-235, 1998
173. Springate JE, Christensen SL, Feld LG:
Serum creatinine level and renal function in children. Am
J Dis Child 146:1232-1235, 1992
174. Waz WR, Quattrin T, Feld LG: Serum
creatinine, height, and weight do not predict glomerular filtration rate in children with
IDDM.
Diabetes Care 16:1067-1070, 1993
175. Bokenkamp A, Domanetzki M, Zinck R,
Schumann G, Byrd D, Brodehl J: Cystatin C—A new marker of glomerular filtration rate
in children independent of age and height. Pediatrics
101:875-881, 1998
176. Stake G, Monn E, Rootwelt K, Golman K,
Monclair T: Influence of urography on renal function in children. A double blind study
with metrizoate and iohexol.
Acta Radiol 30:643-646, 1989
177. Stake G, Monn E, Rootwelt K, Monclair T:
The clearance of iohexol as a measure of the glomerular filtration rate in children with
chronic renal failure. Scand
J Clin Lab Invest 51:729-734, 1991
178. Stake G, Monn E, Rootwelt K, Monclair T: A
single plasma sample method for estimation of the glomerular filtration rate in infants
and children using iohexol. II: Establishment of the optimal plasma sampling time and a
comparison with the 99Tcm-DTPA method. Scand
J Clin Lab Invest 51:343-348, 1991
179. Stake G, Monclair T: A single plasma sample
method for estimation of the glomerular filtration rate in infants and children using
iohexol. I: Establishment of a body weight-related formula for the distribution volume of
iohexol. Scand
J Clin Lab Invest 51:335-342, 1991
180. Stake G, Monn E, Rootwelt K, Gronberg T,
Monclair T: Glomerular filtration rate estimated by X-ray fluorescence technique in
children: Comparison between the plasma disappearance of 99Tcm-DTPA and iohexol after
urography. Scand
J Clin Lab Invest 50:161-167, 1990
181. Walser M: Assessing renal function from
creatinine measurements in adults with chronic renal failure. Am
J Kidney Dis 32:23-31, 1998
182. Arant BS Jr, Greifer I, Edelmann CM Jr,
Spitzer A: Effect of chronic salt and water loading on the tubular defects of a child with
Fanconi syndrome (cystinosis). Pediatrics
58:370-377, 1976
183. Randers E, Erlandsen E: Serum cystatin C as
an endogenous marker of the renal function—A review. Clin
Chem Lab Med 37:389-395, 1999
184. Holliday MA, Heilborn D, Al-Uzri A, Hidayat
J, Uauy R, Conley SB, Reisch J, Hogg RJ: Serial measurements of GFR in infants using the
continuous iothalamate infusion technique. Kidney
Int 43:893-898, 1993
185. Hellerstein S, Alon US, Warady BA:
Creatinine for estimation of glomerular filtration rate. Pediatr
Nephrol 6:507-511, 1992
186. Winterborn MH, Beetham R, White RHR:
Comparison of plasma disappearance and standard clearance techniques for measuring
glomerular filtration rate in children with and without vesico-ureteric reflux. Clin
Nephrol 7:262-270, 1977
187. Schwartz GJ, Brion LP, Spitzer A: The use
of plasma creatinine concentration for estimating glomerular filtration rate in infants,
children, and adolescents. Pediatr
Clin North Am 34:571-590, 1987
188. Ross JW, Miller WG, Myers GL, Praestgaard
J: The accuracy of laboratory measurements in clinical chemistry: A study of 11 routine
chemistry analytes in the College of American Pathologists Chemistry Survey with fresh
frozen serum, definitive methods, and reference methods. Arch
Pathol Lab Med 122:587-608, 1998
189. Chiou WL, Hsu FH: A new simple and rapid
methd to monitor the renal function based on pharmacokinetic consideration of endogenous
creatinine. Res
Commun Chem Pathol Pharmacol 10:315-330, 1975
190. Kwong MB, Tong TK, Mickell JJ, Chan JC:
Lack of evidence that formula-derived creatinine clearance approximates glomerular
filtration rate in pediatric intensive care population. Clin
Nephrol 24:285-288, 1985
191. Jacobson P, West N, Hutchinson RJ:
Predictive ability of creatinine clearance estimate models in pediatric bone marrow
transplant patients. Bone
Marrow Transplant 19:481-485, 1997
192. Fong J, Johnston S, Valentino T, Notterman
D: Length/serum creatinine ratio does not predict measured creatinine clearance in
critically ill children. Clin
Pharmacol Therapeutics 58:192-197, 1995
193. Gbadegesin RA, Adeyemo AA, Asinobi AO,
Osinusi K: Inaccuracy of the Schwartz formula in estimating glomerular filtration rate in
Nigerian children. Ann
Trop Paediatr 17:179-185, 1997
194. Rocco MV, Buckalew VM Jr, Moore LC, Shihabi
ZK: Capillary electrophoresis for the determination of glomerular filtration rate using
nonradioactive iohexol. Am
J Kidney Dis 28:173-177, 1996
195. Zelmanovitz T, Gross JL, Oliveira J, de
Azevedo MJ: Proteinuria is still useful for the screening and diagnosis of overt diabetic
nephropathy. Diabetes
Care 21:1076-1079, 1998
196. Zelmanovitz T, Gross JL, Oliveira JR, Paggi
A, Tatsch M, Azevedo MJ: The receiver operating characteristics curve in the evaluation of
a random urine specimen as a screening test for diabetic nephropathy. Diabetes
Care 20:516-519, 1997
197. Ahn CW, Song YD, Kim JH, Lim SK, Choi KH,
Kim KR, Lee HC, Huh KB: The validity of random urine specimen albumin measurement as a
screening test for diabetic nephropathy. Yonsei Med J
40:40-45, 1999
198. Schwab SJ, Dunn FL, Feinglos MN: Screening
for microalbuminuria. A comparison of single sample methods of collection and techniques
of albumin analysis. Diabetes
Care 15:1581-1584, 1992
199. Ng WY, Lui KF, Thai AC: Evaluation of a
rapid screening test for microalbuminuria with a spot measurement of urine
albumin-creatinine ratio. Ann
Acad Med Singapore 29:62-65, 2000
200. Ciavarella A, Silletti A, Forlani G,
Morotti L, Borgnino LC, D’Apote M, Vannini P: A screening test for microalbuminuria
in type 1 (insulin-dependent) diabetes. Diabetes
Res Clin Practice 7:307-312, 1989
201. Webb DJ, Newman DJ, Chaturvedi N, Fuller
JH: The use of the Micral-Test strip to identify the presence of microalbuminuria in
people with insulin dependent diabetes mellitus (IDDM) participating in the EUCLID study. Diabetes
Res Clin Practice 31:93-102, 1996
202. Poulsen PL, Hansen B, Amby T, Terkelsen TE,
Mogensen C: Evaluation of a dipstick test for microalbuminuria in three different clinical
settings, including the correlation with urinary albumin excretion rate. Diabetes
Metab 18:395-400, 1992
203. Gerber LM, Johnston K, Alderman MH:
Assessment of a new dipstick test in screening for microalbuminuria in patients with
hypertension. Am
J Hypertens 11:1321-1327, 1998
204. Schwab SJ, Christensen RL, Dougherty K,
Klahr S: Quantitation of proteinuria by the use of protein-to-creatinine ratios in single
urine samples. Arch
Intern Med 147:943-944, 1987
205. Ginsberg JM, Chang BS, Matarese RA, Garella
S: Use of single voided urine samples to estimate quantitative proteinuria. N
Engl J Med 309:1543-1546, 1983
206. Rodby RA, Rohde RD, Sharon Z, Pohl MA, Bain
RP, Lewis EJ: The urine protein to creatinine ratio as a predictor of 24-hour urine
protein excretion in type 1 diabetic patients with nephropathy. The Collaborative Study
Group. Am
J Kidney Dis 26:904-909, 1995
207. Wilson DM, Anderson RL: Protein-osmolality
ratio for the quantitative assessment of proteinuria from a random urinalysis sample. Am
J Clin Pathol 100:419-424, 1993
208. Chu NF, Ferng SH, Shieh SD, Fan CD, Shyh
TP, Chu PL: Assessment of proteinuria by using the protein/creatinine ratio of
single-voided urine. J
Formos Med Assoc 89:657-660, 1990
209. Steinhauslin F, Wauters JP: Quantitation of
proteinuria in kidney transplant patients: Accuracy of the urinary protein/creatinine
ratio. Clin
Nephrol 43:110-115, 1995
210. Nathan DM, Rosenbaum C, Protasowicki VD:
Single-void urine samples can be used to estimate quantitative microalbuminuria. Diabetes
Care 10:414-418, 1987
211. Cottiero RA, Madaio MP, Levey AS:
Glomerular filtration rate and urinary albumin excretion rate in systemic lupus
erythematosus. Nephron
140:140-146, 1995
212. Yoshimoto M, Tsukahara H, Saito M, Hayashi
S, Haruki S, Fujiswana S, Sudo M: Evaluation of variability of proteinuria indices. Pediatr
Nephrol 4:136-139, 1990
213. Iyer RS, Shailaja SN, Bhaskaranand N,
Baliga M, Venkatesh A: Quantitation of proteinuria using protein-creatinine ratio in
random urine samples. Indian
Pediatr 28:463-467, 1991
214. Chahar OP, Bundella B, Chahar CKJ, Purohit
M: Quantitation of proteinuria by use of single random spot urine collection.
J Indian Med Assoc 91:86-87, 1993
215. Mir S, Kutukcular N, Cura A: Use of single
voided urine samples to estimate quantitative proteinuria in children. Turk
J Pediatr 34:219-224, 1992
216. Houser MT: Assessment of proteinuria using
random urine samples. J
Pediatr 104:845-848, 1984
217. Abitbol C, Zilleruelo G, Freundlich M,
Strauss J: Quantitation of proteinuria with urinary protein/creatinine ratios and random
testing with dipsticks in nephrotic children.
J Pediatr 166:243-224, 1990
218. Sochett E, Daneman D: Screening tests to
detect microalbuminuria in children with diabetes. J
Pediatr 112:744-748, 1988
219. Fivush BA, Jabs K, Sullivan EK, Feld LG,
Kohaut E, Fine RN: Chronic renal insufficiency in children and adolescents: the 1996
annual report of NAPRTCS. North American Pediatric Renal Transplant Cooperative Study
(NAPRTCS). Pediatr
Nephrol 12:328-377, 1998
220. Kitagawa T: Lessons learned from the
Japanese nephritis screening study. Pediatr
Nephrol 2:256-263, 1998
221. Committee on Practice and Ambulatory
Medicine: Recommendations for preventive pediatric health care. Pediatrics
96:1-4, 1995
222. Kaplan RE, Springate JE, Feld LG: Screening
dipstick analysis: A time to change. Pediatrics
100:919-921, 1997
223. American Diabetes Association: Diabetic
nephropathy. Diabetes Care 21:S50-S53, 1998
224. The EUCLID Study Group: Randomised
placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent
diabetes and normoalbuminuria or microalbuminuria. Lancet
349:1787-1792, 1997
225. Mathiesen ER, Hommel E, Hansen HP, Smidt
UM, Parving H-H: Randomised controlled trial of long term efficacy of captopril on
preservation of kidney function in normotensive patients with insulin dependent diabetes
and microalbuminuria. BMJ
319:24-25, 1999
226. Ruggenenti P, Pagano E, Tammuzzo L, Benini
R, Garattini L: Gruppo Italiano Di Studi Epidemilogici in Nefrologia (GISEN). Kidney
Int 59:286-294, 2001
227. Wang PH: When should ACE inhibitors be
given to normotensive patients with IDDM? Lancet
349:1782-1783, 1997
228. Grimm RH Jr, Svendsen KH, Kasiske B, Keane
WF, Wahi MM: Proteinuria is a risk factor for mortality over 10 years of follow-up. MRFIT
Research Group. Multiple Risk Factor Intervention Trial. Kidney
Int 63:S10-S14, 1997 (suppl 63)
229. Couper JJ, Clarke CF, Byrne GC, Jones TW,
Donaghue KC, Nairn J, Boyce D, Russell M, Stephens M, Raymond J, Bates DJ, McCaul K:
Progression of borderline increases in albuminuria in adolescents with insulin-dependent
diabetes mellitus. Diabet
Med 14:766-771, 1997
230. Levey AS, Perrone RD, Madaio MP: Laboratory
assessment of renal disease: Clearance, urinalysis and renal biopsy, in Brenner BM, Rector
FR (eds): The Kidney. Philadelphia, PA, W.B. Saunders, 1991, pp 919-968
231. Norden AG, Scheinman SJ, Deschodt-Lanckman
MM, Lapsley M, Nortier JL, Thakker RV, Unwin RJ, Wrong O: Tubular proteinuria defined by a
study of Dent’s (CLCN5 mutation) and other tubular diseases. Kidney
Int 57:240-249, 2000
232. Tomlinson PA, Smellie JM, Prescod N, Dalton
RN, Chantler C: Differential excretion of urinary proteins in children with vesicoureteric
reflux and reflux nephropathy. Pediatr
Nephrol 8:21-25, 1994
233. Weitgasser R, Schnoell F, Gappmayer B,
Kartnig I: Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect
to macrovascular disease in elderly type 2 diabetic patients. Diabetes Care 22:1882-1886,
1999
234. Kordonouri O, Hartmann R, Mueller C, Danne
T, Weber B: Predictive value of tubular markers for the development of microalbuminuria in
adolescents with diabetes. From
the Hormone Res 50:S23-S27, 1998 (suppl 1)
235. Reichert LJ, Koene RA, Wetzels JF: Urinary
IgG excretion as a prognostic factor in idiopathic membranous nephropathy. Clin
Nephrol 48:79-84, 1997
236. Bazzi C, Petrini C, Rizza V, Arrigo G,
Beltrame A, D’Amico G: Characterization of proteinuria in primary
glomerulonephritides. SDS-PAGE patterns: Clinical significance and prognostic value of low
molecular weight (“tubular”) proteins. Am
J Kidney Dis 29:27-35, 1997
237. Woo KT, Lau YK, Lee GS, Wei SS, Lim CH:
Pattern of proteinuria in IgA nephritis by SDS-PAGE: Clinical significance. Clin
Nephrol 36:6-11, 1991
238. Reichert LJ, Koene RA, Wetzels JF: Urinary
excretion of beta 2-microglobulin predicts renal outcome in patients with idiopathic
membranous nephropathy.
J Am Soc Nephrol 6:1666-1669, 1995
239. Hara M, Yanagihara T, Itoh M, Matsuno M,
Kihara I: Immunohistochemical and urinary markers of podocyte injury. Pediatr
Nephrol 12:43-48, 1998
240. Hara M, Yanagihara T, Takada T, Itoh M,
Matsuno M, Yamamoto T, Kihara I: Urinary excretion of podocytes reflects disease activity
in children with glomerulonephritis. Am
J Nephrol 18:35-41, 1998
241. Hotta O, Taguma Y, Ooyama M, Yusa N, Nagura
H: Analysis of CD14+ cells and CD56+ cells in urine using flow
cytometry: A useful tool for monitoring disease activity of IgA nephropathy. Clin
Nephrol 39:289-294, 1993
242. Nakamura T, Ushiyama C, Suzuki S, Hara M,
Shimada N, Sekizuka K, Ebihara I, Koide H: Urinary podocytes for the assessment of disease
activity in lupus nephritis. Am
J Med Sci 320:112-116, 2000
243. Nakamura T, Ushiyama C, Suzuki S, Hara M:
Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol
Dial Transplant 15:1379-1383, 2000
244. Wilson PW, Culleton BF: Epidemiology of
cardiovascular disease in the United States. Am
J Kidney Dis 32:S56-S65, 1998 (suppl 3)
245. The Sixth Report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC
VI). Bethesda, MD, US Department of Health and Human Services, Public Health Service,
National Institutes of Health, National Heart, Lung and Blood Institute, 1997
246. Burt VL, Cutler JA, Higgins M, Horan MJ,
Labarthe D, Whelton P, Brown C, Roccella EJ: Trends in the prevalence, awareness,
treatment, and control of hypertension in the adult US population. Data from the health
examination surveys, 1960-1991. Hypertension 26:6069, 1995
(erratum 27:1192, 1996)
247. Wright JT Jr, Douglas JG, Rahman M:
Prevention of cardiovascular disease in hypertensive patients with normal renal function. Am
J Kidney Dis 32:S66-S79, 1998 (suppl 3)
248. Mailloux LU, Levey AS. Hypertension in
chronic renal disease. Am
J Kidney Dis 32:S120-S141, 1998 (suppl 3)
249. Bakris GL, Williams M, Dworkin L, Elliott
WJ, Epstein M, Toto RDA, Tuttle K, Douglas J, Hsueh W, Sowers J: Preserving renal function
in adults with hypertension and diabetes: A consensus approach. National Kidney Foundation
Hypertension and Diabetes Executive Committees Working Group.
Am J Kidney Dis 36:646-661, 2000
250. HCFA-1995: 1995 Annual Report. ESRD core
indicator project. Opportunities to improve care for adult in-center hemodialysis
patients. Baltimore, MD, Health Care Financing Administration, DHHS, 1996
251. Rocco MV, Flanagan MJ, Beaver S, Frederick
P, Gentile DI, McClellan WM, Polder J, Prowant BF, Taylor L, Helgersson SD: Report from
the 1995 core indicators for peritoneal dialysis study group. Am
J Kidney Dis 30:165-173, 1997
252. National High Blood Pressure Education
Program Working Group. 1995 Update of the working group reports on chronic renal failure
and renovascular hypertension. Arch
Intern Med 156:1938-1947, 1995
253. Parving HH, Andersen AR, Smidt UM: Early
aggressive antihypertensive treatment reduces rate of decline in kidney function in
diabetic nephropathy. Lancet
1:1175-1179, 1983
255. Peterson JC, Adler S, Burkart JM, Greene T,
Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL: Blood pressure control,
proteinuria and the progression of renal disease: The Modification of Diet in Renal
Disease Study. Ann
Intern Med 123:754-762, 1995
256. Opelz G, Wujciak T, Ritz E: The
Collaborative Transplant Study. Association of chronic kidney graft failure with recipient
blood pressure. Kidney
Int 53:217-222, 1998
257. Levin A, Singer J, Thompson CR: Prevalent
left ventricular hypertrophy in the predialysis population: Identifying opportunities for
intervention. Am
J Kidney Dis 27:347-354, 1996
258. Lazarus JM, Bourgoignie JJ, Buckalew VM Jr,
Milas NC, Paranandi L, Peterson JC, Porush JG, Rauch S, Soucie JM, Stollar C: Achievement
and safety of a low blood pressure goal in chronic renal disease. Modification of Diet in
Renal Disease Study Group. Hypertension 29:641-650,
1997
259. Jungers P, Massy ZA, Nguyen Khoa T, Fumeron
C, Labrunie M, Lacour B, Descamps-Latscha B, Man NK: Incidence and risk factors of
atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A
prospective study. Nephrol
Dial Transplant 12:2597-2602, 1997
260. Foley RN, Parfrey PS, Harnett JD, Dent FM,
Murray DC, Barre PC: Impact of hypertension on cardiomyopathy, morbidity and mortality in
end-stage renal disease. Kidney
Int 49:1379-1385, 1996
261. Foley RN, Parfrey PS, Sarnak MJ: Clinical
epidemiology of cardiovascular disease in chronic renal disease. Am
J Kidney Dis 32:112-119, 1998
262. Zagar PG, Nikolic J, Brown RH, Campbell MA,
Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler
JH, Teredesai P: “U” curve association of blood pressure and mortality in
hemodialysis patients. Kidney
Int 54:561-569, 1998
263. Buckalew VM Jr, Berg RL, Wang SR, Porush
JG, Rauch S, Schulman G: Prevalence of hypertension in 1,795 subjects with chronic renal
disease: The modification of diet in renal disease study baseline cohort. Modification of
Diet in Renal Disease Study Group. Am
J Kidney Dis 28:811-821, 1996
265. NKF-DOQI clinical practice guidelines for
the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis
Outcomes Quality Initiative. Am
J Kidney Dis 30:S192-S240, 1997 (suppl 3)
266. NKF-K/DOQI Clinical Practice Guidelines for
Anemia of Chronic Kidney Disease: Update 2000. Am
J Kidney Disease 77:S182-S288, 2001 (suppl 1)
267. McGonigle RJ, Wallin JD, Shadduck RK,
Fisher JW: Erythropoietin deficiency and inhibition of erythropoiesis in renal
insufficiency. Kidney
Int 25:437-444, 1984
268. Radtke HW, Claussner A, Erbes PM,
Scheuermann EH, Schoeppe W, Koch KM: Serum erythropoietin concentration in chronic renal
failure: Relationship to degree of anemia and excretory renal function. Blood
54:877-884, 1979
269. Loge JP, Lange RD, Moore CV:
Characterization of the anemia associated with chronic renal insufficiency. Am J Med 24,
1958
270. Ross RP, McCrea JB, Besarab A:
Erythropoietin response to blood loss in hemodialysis patients is blunted but preserved. ASAIO
J 40:M880-M885, 1994
271. Naets JP, Garcia JF, Tousaaint C, Buset M,
Waks D: Radioimmunoassay of erythropoietin in chronic uraemia of anephric patients. Scand
J Haematol 37:390-394, 1986
272. World Health Organization: Nutritional
Anemia. Report of a WHO Scientific Group. Geneva, Switzerland, WHO, 1968
273. Working Party for European Best Practice
Guidelines for the Management of Anaemia in Patients With Chronic Renal Failure: European
best practice guidelines for the management of anaemia in patients with chronic renal
failure. Nephrol
Dial Transplant 14:1-50, 1999 (suppl 5)
274. Erslev AJ, Besarab A: The rate and control
of baseline red cell production in hema-tologically stable uremic patients.
J Lab Clin Med 126:283-286, 1995
275. Fisher JW: Mechanism of the anemia of
chronic renal failure. Nephron
25:106-111, 1980
276. Besarab A, Levin A: Defining a renal anemia
management period. Am
J Kidney Dis 36:S13-S23, 2000
277. Chandra M, Miller ME, Garcia JF, Mossey RT,
McVicar MI: Serum immunoreactive erythropoietin levels in patients with polycystic kidney
disease as compared with other hemodialysis patients. Nephron
39:26-29, 1985
278. Eschbach JW Jr, Funk D, Adamson J, Kuhn I,
Scribner BH, Finch CA: Erythropoiesis in patients with renal failure undergoing chronic
dialysis.
N Engl J Med 276:653-688, 1967
279. Collins AJ, Ma JZ, Xia A, Ebben J: Trends
in anemia treatment with erythropoietin usage and patient outcomes. Am
J Kidney Dis 32:S133-S141, 1998 (suppl 4)
280. Parfrey PS, Foley RN, Harnett JD, Kent GM,
Murray DC, Barre PE: Outcome and risk factors for left ventricular disorders in chronic
uraemia. Nephrol
Dial Transplant 11:1277-1285, 1996
281. Levin A, Foley RN: Cardiovascular disease in
chronic renal insufficiency. Am
J Kidney Dis 36:S24-S30, 2000 (suppl 3)
282. Kausz AT, Obrador GT, Pereira BJ: Anemia
management in patients with chronic renal insufficiency. Am
J Kidney Dis 36:S39-S51, 2000 (suppl 3)
283. Locatelli F, Conte F, Marcelli D: The
impact of hematocrit levels and Erythropoietin treatment on overall and cardiovascular
mortality and morbidity: The experience of Lombardy Registry. NDT 13:1642-1644, 1998
284. Muirhead N, for the Canadian Erythropoietin
Study Group: Association between recombinant human erythropoietin and quality of life and
exercise capacity of patients receiving haemodialysis. BMJ
300:573-578, 1990
285. The US Recombinant Erythropoietin
Predialysis Study Group: Double-blind, placebo controlled study of the therapeutic use of
recombinant human erythropoietin for anemia associated with chronic renal failure in
predialysis patients. Am
J Kidney Dis 18:50-59, 1991
286. Austrian Multicenter Study Group of rHuEPO
in predialysis patients: Effectiveness and safety of recombinant human erythropoietin in
predialysis patients. Nephron
61:399-403, 1992
287. Winearls CG: Recombinant human
erythropoietin: 10 years of clinical experience. Nephrol
Dial Transplant 13:3-8, 1998
288. Levin A, Thompson CR, Ethier J, Carlisle
EJ, Tobe S, Mendelssohn D, Burgess E, Jindal K, Barrett B, Singer J, Djurdjev O: Left
ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am
J Kidney Dis 34:125-134, 1999
289. Taralov Z, Koumtchev E, Lyutakova Z:
Erythrocyte ferritin levels in chronic renal failure patients. Folia
Medica (Plovdiv) 40:65-70, 1998
290. Clyne N, Jogestrand T, Lins LE, Pehrsson
SK: Progressive decline in renal function induces a gradual decrease in total hemoglobin
and exercise capacity. Nephron
67:322-326, 1994
291. Ishimura E, Nishizawa Y, Okuno S, Matsumoto
N, Emoto M, Inaba M, Kawagishi T, Kim CW, Morii H: Diabetes mellitus increases the
severity of anemia in non-dialyzed patients with renal failure. J
Nephrol 11:83-86, 1998
292. de Klerk G, Wilmink JM, Rosengarten PC, Vet
RJ, Goudsmit R: Serum erythropoietin (ESF) titers in anemia of chronic renal failure. J
Lab Clin Med 100:720-734, 1982
293. Urabe A, Saito T, Fukamachi H, Kubota M,
Takaku F: Serum erythropoietin titers in the anemia of chronic renal failure and other
hematological states. Int
J Cell Cloning 5:202-208, 1987
294. Silverberg DS, Iaina A, Peer G, Kaplan E,
Levi BA, Frank N, Steinbruch S, Blum M: Intravenous iron supplementation for the treatment
of the anemia of moderate to severe chronic renal failure patients not receiving dialysis.
Am
J Kidney Dis 27:234-238, 1996
295. Lin JL, Kou MT, Leu ML: Effect of long-term
low-dose aluminum-containing agents on hemoglobin synthesis in patients with chronic renal
insufficiency. Nephron
74:33-38, 1996
296. Clyne N, Jogestrand T: Effect of
erythropoietin treatment on physical exercise capacity and on renal function in
predialytic uremic patients. Nephron
60:390-396, 1992
297. Portoles J, Torralbo A, Martin P, Rodrigo
J, Herrero JA, Barrientos A: Cardiovascular effects of recombinant human erythropoietin in
predialysis patients. Am
J Kidney Dis 29:541-548, 1997
298. Dimitrakov D, Kumchev E, Tllkian E: Study
of the effect of recombinant erythropoietin on renal anaemia in predialysis patients with
chronic renal failure. Folia
Medica (Plovdiv) 36:31-36, 1994
299. Klahr S, Breyer JA, Beck GJ, Dennis VW,
Hartman JA, Roth D, Steinman TI, Wang SR, Yamamoto ME: Dietary protein restriction, blood
pressure control, and the progression of polycystic kidney disease. Modification of Diet
in Renal Disease Study Group. J
Am Soc Nephrol 5:2037-2047, 1995 (erratum 6:1318, 1995)
300. Howard AD, Moore J Jr, Welch PG, Gouge SF:
Analysis of the quantitative relationship between anemia and chronic renal failure. Am
J Med Sci 297:309-313, 1989
301. Lim VS, Fangman J, Flanigan MJ, DeGowin RL,
Abels RT: Effect of recombinant human erythropoietin on renal function in humans. Kidney
Int 37:131-136, 1990
302. Besarab A, Caro J, Jarrell B, Burke J,
Francos G, Mallon E, Karsch R: Effect of cyclosporine and delayed graft function on
posttransplantation erythropoiesis. Transplantation
40:624-631, 1985
303. Brod J, Hornych A: Effect of correction of
anemia on the glomerular filtration rate in chronic renal failure. Isr
J Med Sci 3:53-59, 1967
304. Roth D, Smith RD, Schulman G, Steinman TI,
Hatch FE, Rudnick MR, Sloand JA, Freedman BI, Williams WW Jr, Shadur CA: Effects of
recombinant human erythropoietin on renal function in chronic renal failure predialysis
patients. Am
J Kidney Dis 24:777-784, 1994
305. Kuriyama S, Tomonari H, Yoshida H,
Hashimoto T, Kawaguchi Y, Sakai O: Reversal of anemia by erythropoietin therapy retards
the progression of chronic renal failure, especially in nondiabetic patients. Nephron
77:176-185, 1997
306. Hayashi T, Suzuki A, Shoji T, Togawa M,
Okada N, Tsubakihara Y, Imai E, Hori M: Cardiovascular effect of normalizing the
hematocrit level during erythropoietin therapy in predialysis patients with chronic renal
failure. Am
J Kidney Dis 35:250-256, 2000
307. Schwartz AB, Prior JE, Mintz GS, Kim KE,
Kahn SB: Cardiovascular hemodynamic effects of correction of anemia of chronic renal
failure with recombinant-human erythropoietin. Transplant
Proc 23:1827-1830, 1991
308. Donnelley S, Shah BE: Erythropoietin
deficiency in hyporeninemia. Am
J Kidney Dis 33:947-953, 1999
309. Chaplin H, Mollison PL: Red cell life span
in nephritis and in hepatic nephrosis. Clin Sci 12:351, 1953
310. Besarab A, Caro J, Jarrell BE, Francos G,
Erslev AJ: Dynamics of erythropoiesis following renal transplantation. Kidney
Int 32:526-536, 1987
311. Cavill I: Iron status as measured by serum
ferritin: The marker and its limitations. Am
J Kidney Dis 34:S12-S17, 1999 (suppl 2)
312. Sunder-Plassmann G, Horl W: Erythropoietin
and iron. Clin
Nephr 47:141-157, 1997
313. Eckard K-U, Möllmann M, Neumann R:
Erythropoietin in polycystic kidney. J
Clin Invest 84:1160-1166, 1989
314. Ikizler TA, Hakim RM: Nutrition in
end-stage renal disease. Kidney
Int 50:343-357, 1996
315. Klahr S, Levey AS, Beck GJ, Caggiula AW,
Hunsicker L, Kusek JW, Striker G: The effects of dietary protein restriction and
blood-pressure control on the progression of chronic renal disease. Modification of Diet
in Renal Disease Study Group. N
Engl J Med 330:877-884, 1994
316. Graham KA, Reaich D, Channon SM, Downie S,
Goodship TH: Correction of acidosis in hemodialysis decreases whole-body protein
degradation. J
Am Soc Nephrol 8:632-637, 1997
317. Position of the American Dietetic
Association: Cost-effectiveness of medical nutrition therapy. J
Am Diet Assoc 95:88-91, 1995
318. Bergstrom J: Nutrition and mortality in
hemodialysis. J
Am Soc Nephrol 6:1329-1341, 1995
319. Lowrie EG, Huang WH, Lew NL, Liu Y: The
relative contribution of measured variables to death risk among hemodialysis patients, in
Friedman EA (ed): Death on Hemodialysis. Amsterdam, The Netherlands, Kluwer Academic,
1994, pp 121-141
320. Hakim RM, Lazarus JM: Initiation of
dialysis. J
Am Soc Nephrol 6:1319-1328, 1995
321. Holland D, Lam M: Predictors of
hopitalization and death amongst pre-dialysis patients: A retrospective study. Nephrol
Dial Transplant 15:650-658, 2000
322. Ikizler TA, Wingard RL, Harvell J, Shyr Y,
Hakim RM: Association of morbidity with markers of nutrition and inflammation in chronic
hemodialysis patients: A prospective study. Kidney
Int 55:1945-1951, 1999
323. Stenvinkel P, Heimburger O, Paultre F,
Diczfalusy U, Wang T, Berglund L, Jogestrand T: Strong association between malnutrition,
inflammation, and atherosclerosis in chronic renal failure. Kidney
Int 55:1899-1911, 1999
324. Kopple JD, Greene T, Chumlea WC, Hollinger
D, Maroni BJ, Merrill D, Scherch LK, Schulman G, Wang SR, Zimmer GS: Relationship between
nutritional status and the glomerular filtration rate: Results from the MDRD study. Kidney
Int 57:1688-1703, 2000
325. Ikizler TA, Greene JH, Wingard RL, Parker
RA, Hakim RM: Spontaneous dietary protein intake during progression of chronic renal
failure. J
Am Soc Nephrol 6:1386-1391, 1995
326. Mitch WE, Maroni BJ: Nutritional
considerations in the treatment of patients with chronic uremia. Miner
Electrolyte Metab 24:285-289, 1998
327. Mitch WE, Maroni BJ: Factors causing
malnutrition in patients with chronic uremia. Am
J Kidney Dis 33:176-179, 1999
328. Ballmer PE, Imoberdorf R: Influence of
acidosis on protein metabolism. Nutrition
11:462-468, 1995
329. Tonshoff B, Blum WF, Mehls O: Derangements
of the somatotropic hormone axis in chronic renal failure. Kidney
Int 58:S106-S113, 1997 (suppl 58)
330. Saborio P, Hahn S, Hisano S, Latta K,
Scheinmann JI, Chan JC: Chronic renal failure: An overview from a pediatric perspective. Nephron
80:134-148, 1998
331. Boirie Y, Breyer M, Gagnadoux MF, Niaudet
P, Bresson JL: Alterations of protein metabolism by metabaolic acidosis in children with
chronic renal failure. Kidney
Int 58:236-241, 2000
332. Panichi V, Migliori M, De Pietro S: C
reactive protein in patients with chronic renal diseases. Ren
Fail 23:551-562, 2001
333. Eustace JA, Astor B, Muntner PM, Ikizler
TA, Coresh J: Inflammation and acidosis are important independent predictors of
hypoalbuminuria in renal insufficiency. J Am Soc Nephrol 12:201A, 2001 (abstr)
334. Bistrian BR: Role of the systemic
inflammatory response syndrome in the development of protein-calorie malnutrition in ESRD.
Am
J Kidney Dis 32:S113-S117, 1998 (suppl 4)
335. Bistrian BRK: The systemic inflammatory
response and its impact on iron nutriture in end-stage renal disease. Am
J Kidney Dis 34:S35-S39, 1999 (suppl 2)
336. Bergstrom J, Lindholm B: Malnutrition,
cardiac disease, and mortality: An integrated point of view. Am
J Kidney Dis 32:834-841, 1998
337. Tom K, Young VR, Chapman T, Masud T, Akpele
L, Maroni BJ: Long-term adaptive responses to dietary protein restriction in chronic renal
failure. Am
J Physiol 268:E668-E677, 1995
338. Kopple JD, Berg R, Houser H, Steinman TI,
Teschan P: Nutritional status of patients with different levels of chronic renal
insufficiency. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney
Int 27:S184-S194, 1989 (suppl 27)
339. Coggins CH, Dwyer JT, Greene T, Petot G,
Snetselaar LG, Van Lente F: Serum lipid changes associated with modified protein diets:
Results from the feasibility phase of the Modification of Diet in Renal Disease Study. Am
J Kidney Dis 23:514-523, 1994
340. Park JS, Jung HH, Yang WS, Kim HH, Kim SB,
Park SK, Hong CD: Protein intake and the nutritional status in patients with pre-dialysis
chronic renal failure on unrestricted diet. Korean
J Intern Med 12:115-121, 1997
341. Pollock CA, Ibels LS, Zhu FY, Warnant M,
Caterson RJ, Waugh DA, Mahony JF: Protein intake in renal disease. J
Am Soc Nephrol 8:777-783, 1997
342. Walser M, Mitch WE, Maroni BJ, Kopple JD:
Should protein intake be restricted in predialysis patients? Kidney
Int 55:771-777, 1999
343. Chauveau P, Barthe N, Rigalleau V, Ozenne
S, Castaing F, Delclaux C: Outcome of nutritional status and body composition of uremic
patients on a very low protein diet. Am
J Kidney Dis 34:500-507, 1999
344. Williams B, Hattersley J, Layward E, Walls
J: Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic
uremia.
Kidney Int 40:779-786, 1991
345. Aparicio M, Chauveau P, De Precigout V,
Bouchet JL, Lasseur C, Combe C: Nutrition and outcome on renal replacement therapy of
patients with chronic renal failure treated by a supplemented very low protein diet. J Am Soc Nephrol 11:708-716, 2000
346. Walser M, Hill SB, Ward L, Magder L: A
crossover comparison of progression of chronic renal failure: Ketoacids versus amino
acids. Kidney
Int 43:933-939, 1993
347. Mazouz H, Kacso I, Ghazali A, El Esper N,
Moriniere P, Makdassi R, Hardy P, Westeel PF, Archard JM, Pruna A, Fournier A: Risk
factors of renal failure progression two years prior to dialysis. Clin
Nephrol 51:355-366, 1999
348. Monteon FJ, Laidlaw SA, Shaib JK, Kopple
JD: Energy expenditure in patients with chronic renal failure. Kidney
Int 30:741-747, 1986
349. Ando A, Orita Y, Nakata K, Tsubakihara Y,
Takamitsu Y, Ueda N, Yanase M, Abe H: Effect of low protein diet and surplus of essential
amino acids on the serum concentration and the urinary excretion of methylguanidine and
guanidinosuccinic acid in chronic renal failure. Nephron
24:161-169, 1979
350. Stenvinkel P, Heimburger O, Tuck CH,
Berglund L: Apo(a)-isoform size, nutritional status and inflammatory markers in chronic
renal failure. Kidney
Int 53:1336-1342, 1998
351. Walser M, Hill S: Can renal replacement be
deferred by a supplemented very low protein diet? J Am Soc Nephrol 10:110-116, 1999
352. Cupisti A, Guidi A, Giovannetti S:
Nutritional state of severe chronic renal failure patients on a low-protein supplemented
diet. Contrib
Nephrol 81:161-168, 1990
353. Sugimoto T, Kikkawa R, Haneda M, Shigeta Y:
Effect of dietary protein restriction on proteinuria in non-insulin-dependent diabetic
patients with nephropathy.
J Nutr Sci Vitaminol 37:S87-S92, 1991 (suppl)
354. Guarnieri G, Toigo G, Situlin R, Crapesi L,
Del Bianco MA, Zanettovich A, Faccini L, Lucchesi A, Oldrizzi L, Rugiu C: Nutritional
assessment in patients with early renal insufficiency on long-term low protein diet. Contrib
Nephrol 53:40-50, 1986
355. Di Landro D, Dattilo GA, Romagnoli GF:
Comparative outcome of patients on a conventional low protein diet versus a supplemented
diet in chronic renal failure. Contrib
Nephrol 81:201-207, 1990
356. Vetter K, Kaschube I, Metzner C, Lindenau
K, Frohling PT: Evaluation of nutritional status in the GDR trial. Contrib
Nephrol 81:208-213, 1990
357. Barsotti G, Ciardella F, Morelli E, Cupisti
A, Mantovanelli A, Giovannetti S: Nutritional treatment of renal failure in type 1
diabetic nephropathy. Clin
Nephrol 29:280-287, 1988
358. Jenkins D, Burton PR, Bennett SE, Baker F,
Walls J: The metabolic consequences of the correction of acidosis in uraemia.
Nephrol Dial Transplant 4:92-95, 1989
359. Huang XH, Rantalaiho V, Wirta O, Pasternack
A, Hiltunen TP, Koivula T, Malminiemi K, Nikkari T, Lehtimaki T: Angiotensin-converting
enzyme insertion/deletion polymorphism and diabetic albuminuria in patients with NIDDM
followed Up for 9 years. Nephron
80:17-24, 1998
360. Zeller K, Whittaker E, Sullivan L, Raskin
P, Jacobson HR: Effect of restricting dietary protein on the progression of renal failure
in patients with insulin-dependent diabetes mellitus. N
Engl J Med 324:78-84, 1991
361. D’Amico G, Gentile MG: Dietary control
may influence several risk factors in patients with chronic renal failure. Contrib
Nephrol 81:29-34, 1990
362. Parillo M, Riccardi G, Pacioni D, Iovine C,
Contaldo F, Isernia C, De Marco F, Perrotti N, Rivellese A: Metabolic consequences of
feeding a high-carbohydrate, high-fiber diet to diabetic patients with chronic kidney
failure. Am
J Clin Nutr 48:255-259, 1988
363. Goodship TH, Mitch WE, Hoerr RA, Wagner DA,
Steinman TI, Young VR: Adaptation to low-protein diets in renal failure: Leucine turnover
and nitrogen balance. J
Am Soc Nephrol 1:66-75, 1990
364. Woodrow G, Oldroyd B, Smith MA, Turney JH:
Measurement of body composition in chronic renal failure: Comparison of skinfold
anthropometry and bioelectrical impedance with dual energy X-ray absorptiometry. Eur
J Clin Nutr 50:295-301, 1996
365. Guarnieri GF, Toigo G, Situlin R, Carraro
M, Tamaro G, Lucchesli A, Oldrizzi L, Rugiu C, Maschio G: Nutritional state in patients on
long-term low-protein diet or with nephrotic syndrome. Kidney
Int 27:S195-S200, 1989 (suppl 27)
366. Maroni BJ, Staffeld C, Young VR, Manatunga
A, Tom K: Mechanisms permitting nephrotic patients to achieve nitrogen equilibrium with a
protein-restricted diet. J Clin
Invest 99:2479-2487, 1997
367. Mitch WE, Walser M, Steinman TI, Hill S,
Zeger S, Tungsanga K: The effect of a keto acid-amino acid supplement to a restricted diet
on the progression of chronic renal failure. N
Engl J Med 311:623-629, 1984
368. Milas NC, Nowack MP, Akpele L, Castaldo L,
Coyne T, Doroshenko L, Kigawa L, Korzec-Ramirez D, Scherch LK, Snetselaar L: Factors
associated with adherence to the dietary protein intervention in the Modification of Diet
in Renal Disease Study. J
Am Diet Assoc 95:1295-1300, 1995
369. Gillis BP, Caggiula AW, Chiavacci AT:
Nutrition intervention program of the Modification of Diet in Renal Disease Study: A
self-management approach. J
Am Diet Assoc 95:1288-1294, 1995
370. Coyne T, Olson M, Bradham K, Garcon M,
Gregory P, Scherch L: Dietary satisfaction correlated with adherence in the Modification
of Diet in Renal Disease Study. J
Am Diet Assoc 95:1301-1306, 1995
371. Dolecek T, Olsen MB, Caggiula AW, Dwyer JT,
Milas C, Gillis BP, Hartmann JA, DiChiro JT: Registered dietitian time requirements in the
Modification of Diet in Renal Disease Study. J
Am Diet Assoc 95:1307-1312, 1995
372. Sherrard DJ, Hercz G, Pei Y, Maloney NA,
Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV: The spectrum of bone disease in
end-stage renal failure—An evolving disorder. Kidney
Int 43:436-442, 1993
373. Bushinsky DA: The contribution of acidosis
to renal osteodystrophy. Kidney
Int 47:1816-1832, 1995
374. Coen G, Manni M, Addari O, Ballanti P,
Pasquali M, Chicca S, Mazzaferro S, Mapoletano I, Napoletano I, Sardella D, Bonucci E:
Metabolic acidosis and osteodystrophic bone disease in predialysis chronic renal failure:
Effect of calcitriol treatment. Miner
Electrolyte Metab 21:375-382, 1995
375. Hsu CH: Are we mismanaging calcium and
phosphate metabolism in renal failure? Am
J Kidney Dis 29:641-649, 1997
376. Sherrard DJ: Control of renal bone disease.
Semin Dial 7:284-287, 1994
377. Slatopolsky E, Bricker NS: The role of
phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal
disease. Kidney
Int 4:141-145, 1973
378. Kates DM, Sherrard DJ, Andress DL: Evidence
that serum phosphate is independently associated with serum PTH in patients with chronic
renal failure. Am
J Kidney Dis 30:809-813, 1997
379. Llach F, Massry SG: On the mechanism of
secondary hyperparathyroidism in moderate renal insufficiency. J
Clin Endocrinol Metab 61:601-606, 1985
380. Budisavljevic M, Cheek D, Ploth D:
Calciphylaxis in chronic renal failure. J
Am Soc Nephrol 7:978-982, 1996
381. Braun J, Oldendorf M, Moshage W, Heidler R,
Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac
calcification in chronic dialysis patients. Am
J Kidney Dis 27:394-401, 1996
382. Andress DL, Maloney NA, Endres DB, Sherrard
DJ: Aluminum-associated bone disease in chronic renal failure: High prevalence in a
long-term dialysis population. J
Bone Miner Res 1:391-398, 1986
383. Ferreira M: Diagnosis of renal
osteodystrophy: When and how to use biochemical markers and non-invasive methods: When
bone biopsy is needed. Nephrol
Dial Transplant 15:S8-S14, 2000 (suppl)
384. Malluche HH, Langub MC, Monier-Faugere MC:
The role of bone biopsy in clinical practice and research. Kidney
Int 73:S20-S25, 1999 (suppl 73)
385. Slatopolsky E, Brown A, Dusso A:
Pathogenesis of secondary hyperparathyroidism. Kidney
Int 73:S14-S19, 1999 (suppl 73)
386. Wang M, Hercz G, Sherrard DJ, Maloney NA,
Segre GV, Pei Y: Relationship between intact 1-84 parathyroid hormone and bone
histomorphometric parameters in dialysis patients without aluminum toxicity. Am
J Kidney Dis 26:836-844, 1995
387. Qi Q, Monier-Faugere MC, Geng Z, Malluche
HH: Predictive value of serum parathyroid hormone levels for bone turnover in patients on
chronic maintenance dialysis. Am
J Kidney Dis 26:622-631, 1995
388. Eastwood JB, Bordier PJ, de Wardener HE:
Some biochemical, histological, radiological and clinical features of renal
osteodystrophy. Kidney
Int 4:128-140, 1973
389. Torres A, Lorenzo V, Hernandez D, Rodriguez
JC, Concepcion MT, Rodriguez AP, Hernandez A, de Bonis E, Darias E, Gonzalez-Posada JM:
Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone
response to PTH. Kidney
Int 47:1434-1442, 1995
390. Slatopolsky E, Finch J, Denda M, Ritter C,
Zhong M, Dusso A, MacDonald PN, Brown AJ: Phosphorus restriction prevents parathyroid
gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97:2534-2540, 1996
391. Wilson L, Felsenfeld A, Drezner MK, Llach
F: Altered divalent ion metabolism in early renal failure: Role of 1,25(OH)2D. Kidney
Int 27:565-573, 1985
392. Hamdy NA, Kanis JA, Beneton MN, Brown CB,
Juttmann JR, Jordans JG, Josse S, Meyrier A, Lins RL, Fairey IT: Effect of alfacalcidol on
natural course of renal bone disease in mild to moderate renal failure. BMJ
310:358-363, 1995
393. Delmez JA, Slatopolsky E.
Hyperphosphatemia: Its consequences and treatment in patients with chronic renal disease. Am
J Kidney Dis 19:303-317, 1992